With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.

Biotechnology

Therapeutics

Paragon Bioservices, Inc.

Pete Buzy

Orlando Lopez

Lynn Betts

Fred Plog

Erica Chacon

Carrie Thompson

Jacqueline Parks

The Quality Assurance Team at Paragon Bioservices, Inc. ensures that all cell and gene therapy products, including AAV, lentiviral vectors, and CAR-T immunotherapies, meet stringent regulatory standards and client specifications. This team oversees compliance, conducts thorough audits, monitors production processes, and verifies that all products adhere to the highest quality standards throughout clinical and commercial manufacturing phases.

Quality Assurance Team

Manufacturing and Production

Scientists and Development

Quality Assurance Team

About

Team members

Other teams at Paragon Bioservices, Inc.

Manufacturing and Production

Scientists and Development